NEW YORK--(BUSINESS WIRE)--
Redwood Shores, Calif.-based Model
N, Inc., a leading revenue management solutions provider to the life
science and technology industries, opened for trading today on the New
York Stock Exchange (NYSE) under the ticker symbol “MODN”
after its initial public offering. GETCO Securities LLC is the
Designated Market Maker for the company’s stock.
Founder, Chairman and CEO Zack Rinat, accompanied by members of Model
N’s leadership team, commemorated the company’s first day of trading by
ringing the NYSE Opening BellSM and visiting the trading
floor to witness the stock opening.
“Becoming a publicly traded company on the NYSE is recognition that
Revenue Management software is a proven source of competitive advantage
for companies in the life sciences and the technology industries.
Furthermore it is a testament to our customers, partners, and employees
daring to pioneer a new software category,” said Zack Rinat, Founder,
Chairman, and CEO of Model N.
“We are delighted to welcome Model N to the NYSE’s growing community of
technology companies,” said Scott R. Cutler, Executive Vice President,
Head of Global Listings, NYSE Euronext. “Model N is a leader in revenue
management solutions offering life science and technology companies
around the globe a suite of innovative tools and services to support
their distinctive business needs. We congratulate Model N on its first
day as a publicly-traded company and look forward to sharing a long and
fruitful partnership with Model N and its shareholders.”
For more information on NYSE Euronext’s listings business and to learn
about trends in the IPO market, please visit the NYSE
Euronext IPO Center.
Photo
1
Caption: Model N, Inc.
Founder, Chairman and CEO Zack Rinat (center, blue tie), joined by
members of the company’s leadership team, rings the NYSE Opening BellSM
to celebrate Model N’s IPO and first day of trading on the NYSE.
Photo
2
Caption: Model N, Inc.
Founder Chairman and CEO Zack Rinat in the center of the trading crowd
(dark blue suit, blue tie) as the company’s stock begins trading on the
NYSE.
About Model N
Model N, a leading provider of Revenue Management Solutions, drives
improved pricing, margin, and revenue performance through a powerful
combination of best practices, highly configurable software
applications, comprehensive services, and actionable analytics across
the complete functional spectrum of pricing, contracting, rebating,
sales, and marketing. Model N leverages its deep industry expertise to
support the unique business needs of Life Sciences and Technology
companies across more than 50 countries. Global Customers include:
Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell,
Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron,
Nokia, Novartis, Novo Nordisk, ON Semiconductor, STMicroelectronics, and
Watson Pharmaceuticals. Whether you are an emerging business or a global
leader, Model N results in revenue. www.modeln.com.
Resources:
Model
N Press Center
Model
N Investor Relations
NYSE Euronext
Media Relations:
Judy Shaw, 212-656-4290
Source: NYSE Euronext